Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Therapy-related myelodysplastic syndrome after autologous stem cell transplantation for breast cancer

Leukemia volume 16, pages 1673–1679 (2002)Cite this article

Abstract

Therapy-related myelodysplastic syndrome and acute myelogenous leukemia (t-MDS/AML) are serious complications of chemotherapy and radiotherapy for cancer. High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) may be associated with an increased incidence of these complications. The frequency of t-MDS/AML after ASCT for breast cancer is uncertain. We reviewed our database of 379 consecutive breast cancer ASCT patients treated with alkylator-based chemotherapy, followed for a median of 1.52 years (range 0–8.97), with a median survival of 6.16 years. Three patients have developed tMDS/AML. The probability of developing this complication at 5 years is 0.032 in our series. We have used pathologic, cytogenetic and molecular methods to evaluate which portions of therapy may have predisposed to the development of this complication. Cytogenetic abnormalities were not found in the stem cell harvests of these patients by metaphase analysis or by fluorescence in situ hybridization (FISH). One patient demonstrated a clonal X chromosome inactivation pattern in her stem cell harvest, indicating pre-transplant chemotherapy may have been responsible for the development of her leukemia. As two of our patients developed this complication at greater than 4 years post-transplant, the number of cases may increase with longer follow-up. While the incidence appears to be low, further prospective and retrospective analysis will be necessary to determine which portions of therapy predispose to the development of t-MDS/AML in patients undergoing ASCT for treatment of breast cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Le Beau MM, Albain KS, Larson RA, Vardiman JW, Davis EM, Blough RR, Golomb HM, Rowley JD . Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7 J Clin Oncol 1986 4: 325–345

    Article  CAS  PubMed  Google Scholar 

  2. Pedersen-Bjergaard J, Sigsgaard TC, Nielsen D, Gjedde SB, Philip P, Hansen M, Larsen SO, Rorth M, Mouridsen H, Dombernowsky P . Acute monocytic or myelomonocytic leukemia with balanced chromsome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer J Clin Oncol 1992 10: 1444–1451

    Article  CAS  PubMed  Google Scholar 

  3. Ballen KK, Antin JH . Treatment of therapy-related acute myelogenous leukemia and myelodysplastic syndromes Heme/Onc Clin N Am 1993 7: 477–493

    Article  CAS  Google Scholar 

  4. Pedersen-Bjergaard J, Andersen MK, Christiansen DH . Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation Blood 2000 95: 3273–3279

    CAS  PubMed  Google Scholar 

  5. Taylor PR, Jackson GH, Lennard AL, Hamilton PJ, Proctor SJ . Low incidence of myelodysplastic syndrome following transplantation using autologous non-cryopreserved bone marrow Leukemia 1997 11: 1650–1653

    Article  CAS  PubMed  Google Scholar 

  6. Darrington DL, Vose JM, Anderson JR, Bierman PJ, Bishop MR, Chan WC, Morris ME, Reed EC, Sanger WG, Tarantolo SR, Weisenburger DD, Kessinger A, Armitage JO . Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies J Clin Oncol 1994 12: 2527–2534

    Article  CAS  PubMed  Google Scholar 

  7. Stone RM, Neuberg D, Soiffer R, Takvorian T, Whelan M, Rabinowe SN, Aster JC, Leavitt P, Mauch P, Freedman AS, Nadler LM . Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma J Clin Oncol 1994 12: 2535–2542

    Article  CAS  PubMed  Google Scholar 

  8. Krishnan A, Bhatia S, Slovak ML, Arber DA, Niland JC, Nademanee A, Fung H, Bhatia R, Kashyap A, Molina A, O'Donnell MR, Parker PA, Sniecinski I, Snyder DS, Spielberger R, Stein A, Forman SJ . Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors Blood 2000 95: 1588–1593

    CAS  PubMed  Google Scholar 

  9. Legare RD, Gribben JG, Maragh M, Hermanowski-Vosatka A, Roach S, Tantravahi R, Nadler LM, Gilliland DG . Prediction of therapy-related acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) after autologous bone marrow transplant (ABMT) for lymphoma Am J Hematol 1997 56: 45–51

    Article  CAS  PubMed  Google Scholar 

  10. Miller JS, Arthur DC, Litz CE, Neglia JP, Miller WJ, Weisdorf DJ . Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer chemotherapy Blood 1994 83: 3780–3786

    CAS  PubMed  Google Scholar 

  11. Pedersen-Bjergaard J, Pedersen M, Myhre J, Geisler C . High risk of therapy-related leukemia after BEAM chemotherapy and autologous stem cell transplantation for previously treated lymphomas is mainly related to primary chemotherapy and not to the BEAM-transplantation procedure Leukemia 1997 11: 1654–1660

    Article  CAS  PubMed  Google Scholar 

  12. Sobecks RM, Le Beau MM, Anastasi J, Williams SF . Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation Bone Marrow Transplant 1999 23: 1161–1165

    Article  CAS  PubMed  Google Scholar 

  13. Milligan DW, Ruiz De Elvira MC, Kolb HJ, Goldstone AH, Meloni G, Rhatiner AZ, Colombat P, Schmitz N . Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow Transplantation Br J Haematol 1999 106: 1020–1026

    Article  CAS  PubMed  Google Scholar 

  14. Micallef IN, Lillington DM, Apostolidis J, Amess JA, Neat M, Matthews J, Clark T, Foran JM, Salam A, Lister TA, Rohatiner AZ . Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignancies J Clin Oncol 2000 18: 947–955

    Article  CAS  PubMed  Google Scholar 

  15. Harrison CN, Gregory W, Hudson GV, Devereux S, Goldstone AH, Hancock B, Winfield D, MacMillan AK, Hoskin P, Newland AC, Milligan D, Linch DC . High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML Br J Cancer 1999 81: 476–483

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Fisher B, Rockette H, Fisher ER, Wickerham DL, Redmond C, Brown A . Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience J Clin Oncol 1985 3: 1640–1658

    Article  CAS  PubMed  Google Scholar 

  17. Geller RB, Boone LB, Karp JE, Davidson N, Selonick SE, Edwards J, Burke PJ . Secondary acute myelocytic leukemia after adjuvant therapy for early-stage breast carcinoma Cancer 1989 64: 629–634

    Article  CAS  PubMed  Google Scholar 

  18. Curtis RE, Boice JD, Stovall M, Bernstein L, Greenberg RS, Flannery JT, Schwartz AG, Weyer P, Moloney WC, Hoover RN . Risk of leukemia after chemotherapy and radiation treatment for breast cancer New Engl J Med 1992 326: 1745–1751

    Article  CAS  PubMed  Google Scholar 

  19. Tallman MS, Gray R, Bennett JM, Variakojis D, Robert N, Wood WC, Rowe JM, Wiernik PH . Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: the Eastern Cooperative Oncology Group experience J Clin Oncol 1995 13: 1557–1563

    Article  CAS  PubMed  Google Scholar 

  20. Laughlin MJ, McGaughey DS, Crews JR, Chao NJ, Rizzieri D, Ross M, Gockerman J, Cirrincione C, Berry D, Mills L, Defusco P, LeGrand S, Peters WP, Vredenburgh JJ . Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant J Clin Oncol 1998 16: 1008–1012

    Article  CAS  PubMed  Google Scholar 

  21. Roman-Unfer S, Bitran JD, Hanauer S, Johnson L, Rita D, Booth C, Chen K . Acute myeloid leukemia and myelodysplasia following intensive chemotherapy for breast cancer Bone Marrow Transplant 1995 16: 163–168

    CAS  PubMed  Google Scholar 

  22. Gale RE, Mein CA, Linch DC . Quantification of X-chromosome inactivation patterns in haematological samples using the DNA PCR-based HUMARA assay Leukemia 1996 10: 362–367

    CAS  PubMed  Google Scholar 

  23. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW . Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation Am J Hum Genet 1992 51: 1229–1239

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Busque L, Zhu J, DeHart D, Griffith B, Willman C, Carroll R, Black P, Gilliland DG . An expression based clonality assay at the human androgen receptor locus (HUMARA) on chromosome X Nucleic Acids Res 1994 22: 697–698

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Anan K, Ito M, Misawa M, Ohe Y, Kai S, Kohsaki M, Hara H . Clonal analysis of peripheral blood and haemopoietic colonies in patients with aplastic anaemia and refractory anaemia using the polymorphic short tandem repeat on the human androgen-receptor (HUMARA) gene Br J Haematol 1995 89: 838–844

    Article  CAS  PubMed  Google Scholar 

  26. Delforge M, Demuynck H, Vandenberghe P, Verhoef G, Zachee P, VanDuppen V, Marijnen P, Van den Berghe H, Boogaerts M . Polyclonal primitive hematopoietic progenitors can be detected in mobilized peripheral blood from patients with high-risk myelodysplastic syndromes Blood 1995 86: 3660–3667

    CAS  PubMed  Google Scholar 

  27. Kassar NE, Hetet G, Li Y, Briere J, Grandchamp B . Clonal analysis of haemopoietic cells in essential thrombocysthemia Br J Haematol 1995 90: 131–137

    Article  PubMed  Google Scholar 

  28. Willman CL, Busque L, Griffith BB, Favara BE, McClain KL, Duncan MH, Gilliland DG . Langerhans’-cell histiocytosis (histiocytosis X) – a clonal proliferative disease New Engl J Med 1994 331: 154–160

    Article  CAS  PubMed  Google Scholar 

  29. Delabesse E, Aral S, Kamoun P, Varet B, Turhan AG . Quantitative non-radioactive clonality analysis of human leukemic cells and progenitors using the human androgen receptor (AR) gene Leukemia 1995 9: 1578–1582

    CAS  PubMed  Google Scholar 

  30. Mach-Pascual S, Legare RD, Lu D, Kroon M, Neuberg D, Tantravahi R, Stone RM, Freedman AS, Nadler LM, Gribben JG, Gilliland DG . Predictive value of clonality assays in patients with non-Hodgkin's lymphoma undergoing autologous bone marrow transplant: a single institution study Blood 1998 91: 4496–4503

    CAS  PubMed  Google Scholar 

  31. Orazi A, Cattoretti G, Soligo D, Luksch R, Lambertenghi-Deliliers G . Therapy-related myelodysplastic syndromes: FAB classification, bone marrow histology and immunohistology in the prognostic assessment Leukemia 1993 7: 838–847

    CAS  PubMed  Google Scholar 

  32. Orazi A, Gordon MS, John K, Sledge G Jr, Neiman RS, Hoffman R . In vivo effects of recombinant human stem cell factor treatment. A morphologic and immunohistochemical study of bone marrow biopsies Am J Clin Path 1995 103: 177–184

    Article  CAS  PubMed  Google Scholar 

  33. Abruzzese E, Radford JE, Miller JS, Vredenburgh JJ, Rao PN, Pettenati MJ, Cruz JM, Perry JJ, Amadori S, Hurd DD . Detection of abnormal pretransplant clones in progenitor cells of patients who developed myelodysplasia after autologous transplantation Blood 1999 94: 1814–1819

    CAS  PubMed  Google Scholar 

  34. Lillington DM, Micallef IN, Carpenter E, Neat MJ, Amess JA, Matthews J, Foot NJ, Young BD, Lister TA, Rohatiner AZ . Detection of chromosomal abnormalities pre-high-dose treatment in patients with leukemia after treatment for non-Hodgkin's lymphoma J Clin Oncol 2001 19: 2472–2481

    Article  CAS  PubMed  Google Scholar 

  35. Busque L, Mio R, Mattioli J, Brais E, Blais N, Lalonde Y, Maragh M, Gilliland DG . Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age Blood 1996 88: 59–65

    CAS  PubMed  Google Scholar 

  36. Jang SJ, Mao L . Methylation patterns in human androgen receptor gene and clonality analysis Cancer Res 2000 60: 864–866

    CAS  PubMed  Google Scholar 

  37. Diamandidou E, Buzdar AU, Smith TL, Frye D, Witjaksono M, Hortobagyi GN . Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: the University of Texas MD Anderson Cancer Center experience J Clin Oncol 1996 14: 2722–2730

    Article  CAS  PubMed  Google Scholar 

  38. Fisher B, Anderson S, DeCillis A, Dimitrov N, Atkins JN, Fehrenbacher L, Henry PH, Romond EH, Lanier KS, Davila E, Kardinal CG, Laufman L, Pierce HI, Abramson N, Keller AM, Hamm JT, Wickerham DL, Begovic M, Tan-Chiu E, Tian W, Wolmark N . Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of breast cancer: findings from the National Surgical Adjuvant Breast and Bowel Project B-25 J Clin Oncol 1999 17: 3374–3388

    Article  CAS  PubMed  Google Scholar 

  39. Bergh J, Wiklund T, Erikstein B, Lidbrink E, Lindman H, Malmstrom P, Kellokumpu-Lehtinen P, Bengtsson NO, Soderlund G, Anker G, Wist E, Ottosson S, Salminen E, Ljungman P, Holte H, Nilsson J, Blomqvist C, Wilking N . Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study Lancet 2000 356: 1384–1391

    Article  CAS  PubMed  Google Scholar 

  40. Carli P, Sgro C, Parchin-Geneste N, Isambert N, Mugneret F, Girodon F, Maynadie M . Increase therapy-related leukemia secondary to breast cancer Leukemia 2000 6: 1014–1017

    Article  Google Scholar 

  41. Chaplain G, Milan C, Sgro C, Carli PM, Bonithon-Kopp C . Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: a population-based study J Clin Oncol 2000 18: 2836–2842

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This research was supported by American Cancer Society Institutional Research Grant #177E and the Herbert Irving Comprehensive Cancer (GN).

Author information

Authors and Affiliations

  1. Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA

    G Nichols, K de Castro, L-X Wei, M Griffin, N Lin, L Vahdat & C Hesdorffer

  2. Department of Pathology, Columbia University College of Physicians and Surgeons, New York, NY, USA

    A Oratzi & VVVS Murty

  3. Department of Biostatistics, Columbia University College of Physicians and Surgeons, New York, NY, USA

    A Troxel

Authors
  1. G Nichols
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K de Castro
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L-X Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Griffin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A Oratzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. VVVS Murty
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A Troxel
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. L Vahdat
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. C Hesdorffer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nichols, G., de Castro, K., Wei, LX. et al. Therapy-related myelodysplastic syndrome after autologous stem cell transplantation for breast cancer. Leukemia 16, 1673–1679 (2002). https://doi.org/10.1038/sj.leu.2402631

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402631

Keywords

This article is cited by

Search

Advanced search

Quick links